A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

OBJECTIVE: The objective of the study was to confirm the efficacy and safety of Astodrimer 1% Gel to prevent recurrence of bacterial vaginosis. STUDY DESIGN: 864 women with a diagnosis of bacterial vaginosis and a history of recurrent bacterial vaginosis were enrolled in North America and first rece...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Obstet Gynecol Reprod Biol X
Main Authors: Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Gynaecology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843408/
https://ncbi.nlm.nih.gov/pubmed/33537666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eurox.2021.100121
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados